Safety Study of Escitalopram in Children 7 to 11 Years of Age With Major Depressive Disorder
Status:
Completed
Trial end date:
2013-04-01
Target enrollment:
Participant gender:
Summary
This study will evaluate the long-term safety and tolerability of escitalopram (Lexapro) in
children 7 to 11 years of age with major depressive disorder (MDD).